ClinicalTrials.Veeva

Menu

Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants (Osciflow)

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Infant, Premature, Diseases
Apnea of Prematurity

Treatments

Device: Osciflow
Device: Highflow

Study type

Interventional

Funder types

Other

Identifiers

NCT04327466
Osciflow

Details and patient eligibility

About

This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.

Enrollment

30 patients

Sex

All

Ages

3+ days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Preterm infants born with a gestational age of <35 weeks
  • >72 hours old
  • On nCPAP with PEEP 5 mbar and FiO2 <0.3

Exclusion criteria

  • Severe congenital malformations adversely affecting life expectancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Osciflow
Experimental group
Description:
Crossover sequence of experimental treatment and active comparator.
Treatment:
Device: Osciflow
Highflow
Active Comparator group
Description:
Crossover sequence of experimental treatment and active comparator.
Treatment:
Device: Highflow

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems